A detailed history of Nisa Investment Advisors, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 18 shares of PDSB stock, worth $39. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 53 66.04%
Holding current value
$39
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$2.93 - $4.23 $102 - $148
-35 Reduced 66.04%
18 $0
Q2 2024

Jul 19, 2024

SELL
$2.55 - $4.02 $15 - $24
-6 Reduced 10.17%
53 $0
Q1 2024

May 01, 2024

BUY
$3.85 - $6.59 $227 - $388
59 New
59 $0

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $61.8M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.